Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

UWE helps fight leukaemia with research into ‘natural killer’ cells

08.03.2006


Scientists at the University of the West of England and the Bone Marrow Transplant Unit at the Bristol Children’s Hospital have just won funding for a two-year project aimed at improving the outcome of bone marrow stem-cell transplants in young leukaemia patients.



After a stem cell transplant there is a significant risk that grafted donor white blood cells, known as T-cells, will attack the recipient and may cause a fatal complication called graft versus host disease (GvHD). In Bristol a monoclonal antibody called Campath is used to kill donor T-cells, reducing the chance of GvHD. A side effect of Campath therapy is delayed recovery of the immune system after the transplant which may be associated with leukaemic relapse.

UWE vice-chancellor Sir Howard Newby commented:


“Medical research is important to us all and especially to children. Basic scientific research cannot guarantee cures but in the longer term this important study could help children unfortunate enough to have to undergo a transplant and their families and friends. This award is evidence of the excellence of scientific research in our city.”

The UWE project will monitor the patient’s immune system to see how quickly it recovers following transplantation. In particular, the researchers are focussing on the role played by ‘natural killer T-cells’ (NKT-cells), which form a tiny but important population of white cells present in the blood of normal individuals including stem cell donors. The UWE group hypothesise that NKT-cells play a vital role killing remaining leukaemic cells in the patient’s system after the transplant thus leading to a higher probability of cure.

After an initial year of successful investigations researchers at UWE have discovered that NKT-cells possess the target antigen for Campath, already known to be present on the surface of T-cells. This means that unfortunately NKT-cells are also likely to be removed by Campath treatment. To investigate this important observation further the UWE researchers have just been awarded £97,000 additional funding by the charity CHILDREN with LEUKAEMIA.

Project leader Dr Craig Donaldson explains: “Initially, the treatment with Campath means the graft ‘takes’ better but unfortunately a significant proportion of transplant patients relapse over time and eventually die of leukemia. An important part of this project is to study the rate of repopulation of vital NKT-cells in patients who have received Campath treated grafts in comparison with patients who do not receive Campath treatment.”

“Patients who have consented to take part in this study will have a research blood sample taken at the same as their routine blood tests before transplant and at 3, 6 and 12 months after transplant. When the stem cell donor is a family member they will also be asked whether they wish to participate by consenting to having a research blood sample being taken when they attend the transplant unit for their routine pre-transplant blood check.”

The Bone Marrow Transplant unit based in the Paul O’Gorman wing of the new Bristol Children’s Hospital has an international reputation for developing novel methods of improving the results of stem cell transplants in young patients with leukaemia. Laboratory studies are being carried out at the Centre for Research in Biomedicine at the University of the West of England by Barbara Rees under the supervision of Dr Craig Donaldson and Professor Jill Hows.

Lesley Drake | alfa
Further information:
http://www.uwe.ac.uk
http://www.leukaemia.org/

More articles from Life Sciences:

nachricht What the world's tiniest 'monster truck' reveals
23.08.2017 | American Chemical Society

nachricht Treating arthritis with algae
23.08.2017 | Empa - Eidgenössische Materialprüfungs- und Forschungsanstalt

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

What the world's tiniest 'monster truck' reveals

23.08.2017 | Life Sciences

Treating arthritis with algae

23.08.2017 | Life Sciences

Witnessing turbulent motion in the atmosphere of a distant star

23.08.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>